Service evaluation of a primary care pathway utilising non-invasive biochemical tests to risk-stratify significant fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
by Ankur Srivastava, Paul Thomas, Nathan WP Cantley, Talal Valliani, Fraser Todd, Alka Joshi
Service evaluation of a primary care pathway utilising non-invasive biochemical tests to risk-stratify significant fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)